The HinduHealth
Experts say row over SMA drug distribution is unwarranted
Hospital authorities in Keralam reject parents’ claims that a free spinal muscular atrophy drug was experimental. They say it was generic risdiplam, made by Natco Pharma, and approved by Indian drug regulators for use in the country.
This card is an AI-assisted summary of reporting published by The Hindu. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.